Biosimilar standards: Compounding circumvents the required comparative testing necessary to ensure similarity in quality, purity and potency
Conclusion IGF-1 LR3 is a synthetic analogue of natural human insulin-like growth factor 1
()
Experts at the National Institutes of Health recognized it as such in 1998with the American Medical Association finally classifying it as a chronic disease, rather than a personal choice, almost ten years ago
Because hepatotoxicity is rare after acute overdose, the lack of transaminase elevation following prophylactic carnitine administration does not demonstrate its hepatoprotective properties
The GH/IGF-1 axis promotes muscle protein synthesis and lean body mass gain, enhances lipolysis and fat oxidation (reducing adipose tissue), stimulates bone formation and mineralization, supports immune function, influences cognitive function and mood, improves sleep quality and architecture, enhances skin collagen production and thickness, and modulates glucose and lipid metabolism
